147 related articles for article (PubMed ID: 26543611)
1. The BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinoma.
Zhang N; Jiang BY; Zhang XC; Xie Z; Su J; Zhang Q; Han JF; Tu HY; Wu YL
J Thorac Dis; 2015 Sep; 7(9):1630-6. PubMed ID: 26543611
[TBL] [Abstract][Full Text] [Related]
2. BCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplification.
Jiang BY; Zhang XC; Su J; Meng W; Yang XN; Yang JJ; Zhou Q; Chen ZY; Chen ZH; Xie Z; Chen SL; Wu YL
Mol Cancer; 2013 Jun; 12():61. PubMed ID: 23758992
[TBL] [Abstract][Full Text] [Related]
3. BCL11A Expression in Non-Small Cell Lung Cancers.
Kątnik E; Gomułkiewicz A; Piotrowska A; Grzegrzółka J; Kmiecik A; Ratajczak-Wielgomas K; Urbaniak A; Glatzel-Plucińska N; Błasiak P; Dzięgiel P
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372998
[TBL] [Abstract][Full Text] [Related]
4. Deciphering clinical significance of BCL11A isoforms and protein expression roles in triple-negative breast cancer subtype.
Angius A; Pira G; Cossu-Rocca P; Sotgiu G; Saderi L; Muroni MR; Virdis P; Piras D; Vincenzo R; Carru C; Coradduzza D; Uras MG; Cottu P; Fancellu A; Orrù S; Uva P; De Miglio MR
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3951-3963. PubMed ID: 36030436
[TBL] [Abstract][Full Text] [Related]
5. BCL11A Promotes the Progression of Laryngeal Squamous Cell Carcinoma.
Zhou J; Zhou L; Zhang D; Tang WJ; Tang D; Shi XL; Yang Y; Zhou L; Liu F; Yu Y; Liu P; Tao L; Lu LM
Front Oncol; 2020; 10():375. PubMed ID: 32266150
[No Abstract] [Full Text] [Related]
6. Expression of bcl-2 protein in stage T1N0M0 non-small cell lung carcinoma.
Ritter JH; Dresler CM; Wick MR
Hum Pathol; 1995 Nov; 26(11):1227-32. PubMed ID: 7590697
[TBL] [Abstract][Full Text] [Related]
7. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated nonsmall cell lung carcinoma: undifferentiated "lymphoepithelioma-like" carcinoma as a distinct entity with better prognosis.
Chen FF; Yan JJ; Lai WW; Jin YT; Su IJ
Cancer; 1998 Jun; 82(12):2334-42. PubMed ID: 9635525
[TBL] [Abstract][Full Text] [Related]
9. NQO1 protein expression predicts poor prognosis of non-small cell lung cancers.
Li Z; Zhang Y; Jin T; Men J; Lin Z; Qi P; Piao Y; Yan G
BMC Cancer; 2015 Mar; 15():207. PubMed ID: 25880877
[TBL] [Abstract][Full Text] [Related]
10. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
Wimmel A; Schilli M; Kaiser U; Havemann K; Ramaswamy A; Branscheid D; Kogan E; Schuermann M
Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
12. Primary tumor standardized uptake value (SUVmax) measured on
Hui Z; Wei F; Ren H; Xu W; Ren X
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2595-2605. PubMed ID: 32494919
[TBL] [Abstract][Full Text] [Related]
13. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of BCL11A expression in ER-negative and PR-negative endometrial carcinoma.
You D; Lin L; Wang Q; Yi T; Zhao L; Li M; Wang P
Int J Clin Exp Pathol; 2018; 11(6):3068-3075. PubMed ID: 31938433
[TBL] [Abstract][Full Text] [Related]
15. Differential Thymidylate Synthase Expression in Different Variants of Large-Cell Carcinoma of the Lung.
Monica V; Scagliotti GV; Ceppi P; Righi L; Cambieri A; Lo Iacono M; Saviozzi S; Volante M; Novello S; Papotti M
Clin Cancer Res; 2009 Dec; 15(24):7547-7552. PubMed ID: 19996214
[TBL] [Abstract][Full Text] [Related]
16. BCL11A Expression in Breast Cancer.
Kątnik E; Gomułkiewicz A; Piotrowska A; Grzegrzółka J; Rusak A; Kmiecik A; Ratajczak-Wielgomas K; Dzięgiel P
Curr Issues Mol Biol; 2023 Mar; 45(4):2681-2698. PubMed ID: 37185699
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
Koh HM; Kim DC; Kim YM; Song DH
Thorac Cancer; 2019 Dec; 10(12):2209-2217. PubMed ID: 31602798
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of Notch ligands and receptors in nonsmall cell lung cancer: coexpression of Notch-1 and vascular endothelial growth factor-A predicts poor survival.
Donnem T; Andersen S; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
Cancer; 2010 Dec; 116(24):5676-85. PubMed ID: 20737536
[TBL] [Abstract][Full Text] [Related]
19. FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non-small cell lung cancer.
Theelen WS; Mittempergher L; Willems SM; Bosma AJ; Peters DD; van der Noort V; Japenga EJ; Peeters T; Koole K; Šuštić T; Blaauwgeers JL; van Noesel CJ; Bernards R; van den Heuvel MM
J Pathol Clin Res; 2016 Oct; 2(4):223-233. PubMed ID: 27785367
[TBL] [Abstract][Full Text] [Related]
20. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
